The abstract is read at the publisher; the summary is JClub's.
TransCirc 2.0 expands an evidence-integrated circRNA translation resource to 10 vertebrate species, covering over 2.8 million circRNAs with ~10-fold increased full-length sequence coverage.
- Why it matters: The field needs a standardized, cross-species way to assess whether circRNAs can be translated and what downstream products they might generate, beyond human-only catalogs.
- What they did: The update integrates multi-level evidence—translation initiation sites, IRES, N6-methyladenosine, ribosome/polysome association, and mass spectrometry—plus circRNA-specific ORF and sequence-composition annotations, and adds TranslationAI/LAMAR predicted regulatory features.
- The result: It links full-length circRNA sequences to translation evidence and downstream annotations, including degron-associated stability and MS-supported peptides for potential MHC-I presentation, enabling systematic evaluation of translation potential and putative products.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.